Northwestern University

The Klein lab at Northwestern University is at the forefront of research into the causes, diagnosis, and treatment of Alzheimer's disease, addressing a pressing health crisis that impacts countless families across the United States. Their groundbreaking work has identified soluble amyloid proteins as potent neurotoxins that play a critical role in the brain damage associated with dementia.

Collaborating with a network of colleagues both locally and globally, the Klein lab focuses on a comprehensive approach encompassing structural biology, nerve cell biology, and drug discovery. Their innovative research has led to the development of sabirnetug, a new Alzheimer's drug candidate that recently completed a successful phase 1 clinical trial, showcasing the lab's commitment to advancing therapeutics in the field.

Generated from the website